CLASS II Device recall · Reported 22 Oct 2014 · FDA Enforcement Report

Philips Expression MR200 MRI Patient Monitoring System recalled

Invivo is recalling Philips Expression MR200 MRI Patient Monitoring System, distributed in California, Georgia, Michigan, New Jersey, Nevada, Texas. The recall was initiated on 5 Sep 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel: 866120, Lot numbers: US33600004, US33600005, US33600006, US33600007, US33600008, US33600009, US33600010, US33600011, US33600012, US33600013, US33600014, US33600015, US33600016, US33600017, US33600018, US33600019, US33600020, US33600022, US33600023, US33600024, US33600025, US33600026, US33600027, US33600028.
Quantity recalled24 units.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0069-2015
FDA event ID
69179
Recalling firm
Invivo, Orlando, FL
Classification
Class II
Status
Terminated
Recall initiated
5 Sep 2014
FDA classified
15 Oct 2014
Reported
22 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction

Timeline

5 Sep 2014Recall initiated by company
15 Oct 2014Classified by FDA+40 days
22 Oct 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failure to produce the Non-Invasive Blood Pressure (NIBP) Measurement.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Philips Expression MR200 MRI Patient Monitoring System

Where it was distributed

Worldwide Distribution - US including the states of CA, GA, MI, NJ, NV, and TX., and the countries of: Austria, Finland, Germany, Poland, Singapore, Sweden, Switzerland and United Kingdom.

CaliforniaGeorgiaMichiganNew JerseyNevadaTexas

Questions about this recall

Why was it recalled?

Failure to produce the Non-Invasive Blood Pressure (NIBP) Measurement.

Which lots are affected?

Model: 866120, Lot numbers: US33600004, US33600005, US33600006, US33600007, US33600008, US33600009, US33600010, US33600011, US33600012, US33600013, US33600014, US33600015, US33600016, US33600017, US33600018, US33600019, US33600020, US33600022, US33600023, US33600024, US33600025, US33600026, US33600027, US33600028.

Where was it sold?

Worldwide Distribution - US including the states of CA, GA, MI, NJ, NV, and TX., and the countries of: Austria, Finland, Germany, Poland, Singapore, Sweden, Switzerland and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Invivo

All 18

Other Imaging Equipment recalls

All 2,347